Your browser doesn't support javascript.
loading
ACG Clinical Guideline: Diagnosis and Management of Gastrointestinal Subepithelial Lesions.
Jacobson, Brian C; Bhatt, Amit; Greer, Katarina B; Lee, Linda S; Park, Walter G; Sauer, Bryan G; Shami, Vanessa M.
Affiliation
  • Jacobson BC; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Bhatt A; Division of Gastroenterology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Greer KB; Department of Medicine, Section of Gastroenterology and Hepatology, Louis Stokes VA Medical Center, Cleveland, Ohio, USA.
  • Lee LS; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Park WG; Division of Gastroenterology & Hepatology, Stanford University School of Medicine, Stanford, California, USA.
  • Sauer BG; University of Virginia, Charlottesville, VA, USA.
  • Shami VM; University of Virginia, Charlottesville, VA, USA.
Am J Gastroenterol ; 118(1): 46-58, 2023 01 01.
Article in En | MEDLINE | ID: mdl-36602835
ABSTRACT
Subepithelial lesions (SEL) of the GI tract represent a mix of benign and potentially malignant entities including tumors, cysts, or extraluminal structures causing extrinsic compression of the gastrointestinal wall. SEL can occur anywhere along the GI tract and are frequently incidental findings encountered during endoscopy or cross-sectional imaging. This clinical guideline of the American College of Gastroenterology was developed using the Grading of Recommendations Assessment, Development, and Evaluation process and is intended to suggest preferable approaches to a typical patient with a SEL based on the currently available published literature. Among the recommendations, we suggest endoscopic ultrasound (EUS) with tissue acquisition to improve diagnostic accuracy in the identification of solid nonlipomatous SEL and EUS fine-needle biopsy alone or EUS fine-needle aspiration with rapid on-site evaluation sampling of solid SEL. There is insufficient evidence to recommend surveillance vs resection of gastric gastrointestinal stromal tumors (GIST) <2 cm in size. Owing to their malignant potential, we suggest resection of gastric GIST >2 cm and all nongastric GIST. When exercising clinical judgment, particularly when statements are conditional suggestions and/or treatments pose significant risks, health-care providers should incorporate this guideline with patient-specific preferences, medical comorbidities, and overall health status to arrive at a patient-centered approach.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastrointestinal Stromal Tumors Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2023 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Gastrointestinal Stromal Tumors Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Am J Gastroenterol Year: 2023 Type: Article Affiliation country: United States